Your briefing

Sunday 3rd August 2025
Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London
Zen Technologies shares gain over 3% after securing Indian patent in defence tech
'Namazvad, not Samajwad': BJP attacks Tejashwi for 'will bin Waqf Act' remark; says 'won't happen'

Your topics

For you

Recommended based on your interests

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved

Made with News.B2BLocal.com Team by New.B2BLocal.com